LIANA+ provides an all-in-one framework for cell–cell communication inference
The growing availability of single-cell and spatially resolved transcriptomics has led to the development of many approaches to infer cell-cell communication, each capturing only a partial view of the complex landscape of intercellular signalling. Here we present LIANA+, a scalable framework built around a rich knowledge base to decode coordinated inter- and intracellular signalling events from single- and multi-condition datasets in both single-cell and spatially resolved data. By extending and unifying established methodologies, LIANA+ provides a comprehensive set of synergistic components to study cell-cell communication via diverse molecular mediators, including those measured in multi-omics data. LIANA+ is accessible at https://github.com/saezlab/liana-py with extensive vignettes ( https://liana-py.readthedocs.io/ ) and provides an all-in-one solution to intercellular communication inference.
Authors
- Julio Sáez-Rodríguez (ORCID: https://orcid.org/0000-0002-8552-8976)
- Pablo Rodríguez-Mier (ORCID: https://orcid.org/0000-0002-4938-4418)
- Aurélien Dugourd (ORCID: https://orcid.org/0000-0002-0714-028X)
- Sebastian Lobentanzer (ORCID: https://orcid.org/0000-0003-3399-6695)
- Ricardo O. Ramirez Flores (ORCID: https://orcid.org/0000-0003-0087-371X)
- Jovan Tanevski (ORCID: https://orcid.org/0000-0001-7177-1003)
- Elias Farr (ORCID: https://orcid.org/0000-0002-4441-6513)
- Daniel Dimitrov (ORCID: https://orcid.org/0000-0002-5197-2112)
- Pau Badia-i-Mompel (ORCID: https://orcid.org/0000-0002-1004-3923)
- Philipp Schäfer (ORCID: https://orcid.org/0009-0008-4403-8592)
Institutions
- European Bioinformatics Institute (GB)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
Publication Details
- Journal
- Nature Cell Biology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1038/s41556-024-01469-w
- Citations
- 167
- Primary Topic
- Molecular Communication and Nanonetworks
- Type
- article
- Field-Weighted Citation Impact
- 30.62
Funders
- Pfizer
- European Commission
- Deutsche Forschungsgemeinschaft